Announcements Trials
Browse Landscape

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Conditions

Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Heart Diseases 3Vascular Diseases 2Small Cell Lung Carcinoma 2Cardiovascular Diseases 2Cardiotoxicity 2Triple Negative Breast Neoplasms 1Recurrence 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Cancer Resectable 1Ovarian Carcinosarcoma 1Neoplasms, Second Primary 1Myelodysplastic Syndromes 1Metabolic Diseases 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Immune-related Adverse Event 1Hematologic Neoplasms 1Heart Failure 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Colorectal Neoplasms 1Colorectal Cancer Metastatic 1Carcinoma, Hepatocellular 1Cancer Therapy-related Cardiovascular Toxicity 1Breast Neoplasms 1Advanced Ovarian Cancer 1

Interventions

Antineoplastic Agents 2Vitamin E 1Plastic Surgery Procedures 1Blood Specimen Collection 1Aspirin 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Vascular Diseases × Antineoplastic Agents × Clear all
NCT06409481 2024-05-10

PARCA

The First Affiliated Hospital of Xinxiang Medical College

Unknown
800,000 enrolled

Cardiovascular Diseases, Heart Diseases, Neoplasms, Vascular Diseases

NCT03882580 2023-04-24

NEOCARDIO

Groupe Hospitalier Pitie-Salpetriere

Unknown
5,000 enrolled

Heart Diseases, Heart Failure, Metabolic Diseases, Vascular Diseases, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡